October 02, 2014 11:44 AM ET

Life Sciences Tools and Services

Company Overview of Life Technologies Corporation

Executive Profile

Gregory T. Lucier

Corporate Advisor, Organovo Holdings, Inc.
AgeTotal Calculated CompensationThis person is connected to 8 Board Members in 8 different organizations across 10 different industries.

See Board Relationships
50--

Background

Mr. Gregory T. Lucier, also known as Greg, has been Corporate Advisor of Organovo Holdings, Inc. since August 6, 2014. Mr. Lucier is Limited Partner of Lakeshore Capital Partners, LLC. He served as Chairman and Chief Executive Officer of Life Technologies Corporation since 2003. He served as the Chief Executive Officer and President of Invitrogen Corp. since May 30, 2003. Mr. Lucier served as the Chief Executive Officer and President at GE Medical Systems Information ...

Corporate Headquarters

5791 Van Allen Way
Carlsbad, California 92008

United States

Phone: 760-603-7200
Fax: 760-602-6500

Board Members Memberships

Former Chairman and Chief Executive Officer
Director
Chairman of the Board of Trustee
Director
Former Director
Chairman of the Board
Former Director
Director
2009-Present
Independent Director and Chairman of Human Resources & Compensation Committee
2013-Present
Director, Member of Audit Committee and Member of Nominating & Corporate Governance Committee
2014-Present
Chairman of The Board

Education

MBA
Harvard Business School
BS
Pennsylvania State University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael D. West Ph.D.Chief Executive Officer, President and Director
BioTime, Inc.
$745.3K
Marc H. Hedrick M.D.Chief Executive Officer, President, Director and Member of Executive Committee
Cytori Therapeutics, Inc.
$406.6K
Robin L. Smith M.D., MBA,RoExecutive Chairman and Chief Executive Officer
Neostem, Inc.
$945.0K
Lode Debrabandere Ph.D., MBAChief Executive Officer, President and Director
Osiris Therapeutics, Inc.
$366.8K
Paul K. Wotton Ph.D.Chief Executive Officer, President, Director and Member of Pricing Committee
Advanced Cell Technology Inc.
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Life Technologies Corporation, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.